Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis
Year: 2012
Type: article
Source: Clinical Cancer Research
Authors: John Mascarenhas, Ronald Hoffman
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2170169485
